A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
Clinical trial NCT06192108 · COMPLETED
Trial details
- NCT number
- NCT06192108
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-10
- Primary completion
- 2025-09-26
- Enrollment
- 962
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.